Skip to main content

Day: April 29, 2022

Aravive Announces Poster Presentations at the 2022 ASCO Annual Meeting

HOUSTON, April 29, 2022 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced the presentation of two poster abstracts at the upcoming American Society of Clinical Oncology (ASCO) 2022 Annual Meeting, to be held in-person on June 3-7, 2022 in Chicago, Illinois. Notably, abstract number 4511 was selected for an oral presentation as part of a Poster Discussion Session.   Abstract Title: A Phase 1b/2 study of batiraxcept (AVB-S6-500) in combination with cabozantinib in patients with advanced or metastatic clear cell renal cell (ccRCC) carcinoma who have received front-line treatment (NCT04300140)Abstract Number: 4511 (Poster Discussion Session – Data will be presented)Poster Session: Genitourinary Cancer—Kidney...

Continue reading

Cara Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022

STAMFORD, Conn., April 29, 2022 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, May 9, 2022, at 4:30 p.m. ET to report first quarter 2022 financial results and provide a corporate update. To participate in the conference call, please dial (855) 445-2816 (domestic) or (484) 756-4300 (international) and refer to conference ID 9296276. A live webcast of the call can be accessed under “Events & Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website beginning approximately...

Continue reading

Microbix Presenting Omicron Test Control Results at CVS

QAPs Supporting Molecular Diagnostic Tests for Dominant COVID-variant MISSISSAUGA, Ontario, April 29, 2022 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will present performance results of its Quality Assessment Products (“QAPs™”) supporting molecular-diagnostic tests for the Omicron variant of the SARS-CoV-2 virus (“Omicron”) at the 2022 Clinical Virology Symposium of the American Society for Microbiology (“CVS”) taking place in West Palm Beach, Florida from May 1-4, 2022. At CVS, Microbix will be exhibiting alongside leading diagnostics firms that provide tests for detection of COVID and other infectious diseases. Microbix will also review performance of its QAPs to support quality management of testing for infection with Omicron...

Continue reading

The Simply Good Foods Company to Participate in the Goldman Sachs Staples Forum

DENVER, April 29, 2022 (GLOBE NEWSWIRE) — The Simply Good Foods Company (NASDAQ:SMPL) (“Simply Good Foods” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today announced that members of the executive management team will participate in a fireside chat at the Goldman Sachs Staples Forum on Tuesday, May 17, 2022 at 8:55 a.m. ET. The live audio webcast will be available at https://www.thesimplygoodfoodscompany.com within the Events and Presentations section of the Company’s website. About The Simply Good Foods CompanyThe Simply Good Foods Company (Nasdaq: SMPL), headquartered in Denver, Colorado, is a highly-focused food company with a product portfolio consisting primarily of nutrition bars, ready-to-drink shakes, sweet and salty snacks and confectionery products marketed under...

Continue reading

IRADIMED CORPORATION Announces First Quarter 2022 Financial Results

Reports first quarter 2022 revenue of $12.3 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.22 Announces second quarter 2022 financial guidance Increases full-year 2022 financial guidanceWINTER SPRINGS, Fla., April 29, 2022 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three months ended March 31, 2022. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures. “I am very satisfied with these results. Having the first quarter start off strongly shows the continued strength of our business. Our growth...

Continue reading

Verano Announces Opening of 45th Florida MÜV Medical Cannabis Dispensary in Hobe Sound

MÜV Hobe Sound is located at 10455 SE Federal Highway, a busy thoroughfare with an average daily traffic count of 25,500 vehicles1 The dispensary is situated on Florida’s famed “Treasure Coast,” an area known for its beaches and tourist attractions Verano’s active operations span 13 states, comprised of 96 dispensaries and 12 cultivation and processing facilities with more than 1 million square feet of cultivation capacityCHICAGO, April 29, 2022 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the opening of MÜV Hobe Sound, the Company’s 45th Florida location and 96th nationwide. MÜV Hobe Sound, located at 10455 SE Federal Highway, is open Monday through Saturday from 9:00 a.m. to 7:00 p.m., and from 11:00 a.m. to 5:00 p.m....

Continue reading

Destination XL Group, Inc. to Announce First Quarter 2022 Financial Results on May 26, 2022

Company to Webcast Conference Call Live at 9:00 a.m. ET CANTON, Mass., April 29, 2022 (GLOBE NEWSWIRE) — Destination XL Group, Inc. (NASDAQ: DXLG), the leading omni-channel specialty retailer of Big + Tall men’s clothing and shoes, announced today it will release its first quarter of fiscal 2022 financial results before the market opens on Thursday, May 26, 2022. President and Chief Executive Officer Harvey Kanter and Executive Vice President, Chief Financial Officer, and Treasurer Peter Stratton will host a conference call the same morning at 9:00 a.m. ET to discuss the results. To listen to the live webcast, visit the “Investor Relations” section of the Company’s website. The live call can also be accessed by dialing: (866) 680-2311. Please reference conference ID: 9575348. An archived version of the webcast...

Continue reading

Supremex Reports Voting Results From its Annual General Meeting

MONTREAL, April 29, 2022 (GLOBE NEWSWIRE) — Supremex Inc. (“Supremex” or the “Company”) (TSX: SXP), a leading North American manufacturer and marketer of envelopes and a growing provider of paper-based packaging solutions, today announced the voting results from its Annual General Meeting of Shareholders held on Thursday April 28, 2022. Voting Results: A total of 11,255,567 common shares were voted at the meeting representing 42.73% of all outstanding shares. Shareholders voted in favour of the election of all directors’ nominees as follows:Nominees % For % WithheldNicole Boivin 98.22 1.78Stewart Emerson 99.11 0.89Robert B. Johnston 91.81 8.19Georges Kobrynsky 99.08 0.92Dany Paradis 99.08 0.92Steven P. Richardson 98.26 1.74Andrew I. (Drew) Sullivan 98.22 1.78Warren J. White 97.38 2.62Appointment of...

Continue reading

WisdomTree Announces First Quarter 2022 Results – Diluted Loss Per Share of ($0.08) (Earnings Per Share of $0.09, as adjusted)

NEW YORK, N.Y., April 29, 2022 (GLOBE NEWSWIRE) — WisdomTree Investments, Inc. (NASDAQ: WETF) today reported financial results for the first quarter of 2022. ($10.3) million net loss ($14.1 (1) million net income, as adjusted), see “Non-GAAP Financial Measurements” for additional information. $17.0 million non-cash charge associated with the revaluation of deferred consideration – gold payments. $79.4 billion of ending AUM, an increase of 2.5% arising from net inflows and market appreciation. $1.3 billion of net inflows, primarily driven by inflows into our fixed income and U.S. equity products, partly offset by outflows from our commodity products. 0.40% average advisory fee, unchanged from the previous quarter. $78.4 million of operating revenues, a decrease of 1.0% due to two fewer revenue days in the quarter, partly offset...

Continue reading

Bitfarms to Report First Quarter 2022 Financial Results on Monday, May 16, 2022

Conference Call to be Held Monday, May 16, 2022, at 11:00 a.m. ET TORONTO, Ontario and BROSSARD, Québec, April 29, 2022 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ: BITF // TSX: BITF), a global Bitcoin self-mining company, will report its fiscal first quarter 2022 financial results on Monday, May 16, 2022, before market opens. Management will host a conference call on Monday, May 16, 2022, at 11:00 a.m. ET to review the financial results. Following management’s formal remarks there will be a question-and-answer session. Pre-submitted questions may be considered and interested parties may submit questions at investors@bitfarms.com through May 13, 2022. Conference call access: Participants are asked to pre-register for the call through the following link:Q1 2022 Conference Call Please note that registered participants will receive their...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.